Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028972225> ?p ?o ?g. }
- W2028972225 endingPage "153" @default.
- W2028972225 startingPage "147" @default.
- W2028972225 abstract "We assessed the risk of occurrence of cancer associated with exposure to metronidazole in the 771 female residents of Rochester, Minnesota, who were treated with metronidazole for vaginal trichomoniasis during the period 1960 through 1969 and were followed up for a total of 12,628 person-years. Standardized morbidity and mortality ratios were determined by using an expected number calculated by applying age-specific incidence rates from Rochester studies and Cancer Surveillance, Epidemiology, and End-Results Reporting (SEER) data to the person-years of follow-up. The overall standardized morbidity ratios for cancer at all sites were 1.4 (Rochester, 1978 through 1983), 1.5 (SEER data for Iowa, 1978 through 1981), and 1.2 (SEER data for Connecticut, 1978 through 1981). By site of the cancers, the standardized morbidity ratios greater than unity were those for malignant lesions of the lung, breast, thyroid, bladder, brain, kidney, nasopharynx, and oral cavity, as well as for multiple myeloma and malignant melanoma; however, the only significantly elevated standardized morbidity ratio was that for bronchogenic carcinoma. After adjustment for smoking status, the standardized morbidity ratio for bronchogenic cancer was 2.5 (95% confidence interval of 1.3 to 4.4). The standardized mortality ratio for cancer at all sites was 1.4 (95% confidence interval of 0.9 to 2.2). The analysis of these data suggests no significant increase in cancer-related morbidity or mortality for women exposed to metronidazole for treatment of vaginal trichomoniasis. We assessed the risk of occurrence of cancer associated with exposure to metronidazole in the 771 female residents of Rochester, Minnesota, who were treated with metronidazole for vaginal trichomoniasis during the period 1960 through 1969 and were followed up for a total of 12,628 person-years. Standardized morbidity and mortality ratios were determined by using an expected number calculated by applying age-specific incidence rates from Rochester studies and Cancer Surveillance, Epidemiology, and End-Results Reporting (SEER) data to the person-years of follow-up. The overall standardized morbidity ratios for cancer at all sites were 1.4 (Rochester, 1978 through 1983), 1.5 (SEER data for Iowa, 1978 through 1981), and 1.2 (SEER data for Connecticut, 1978 through 1981). By site of the cancers, the standardized morbidity ratios greater than unity were those for malignant lesions of the lung, breast, thyroid, bladder, brain, kidney, nasopharynx, and oral cavity, as well as for multiple myeloma and malignant melanoma; however, the only significantly elevated standardized morbidity ratio was that for bronchogenic carcinoma. After adjustment for smoking status, the standardized morbidity ratio for bronchogenic cancer was 2.5 (95% confidence interval of 1.3 to 4.4). The standardized mortality ratio for cancer at all sites was 1.4 (95% confidence interval of 0.9 to 2.2). The analysis of these data suggests no significant increase in cancer-related morbidity or mortality for women exposed to metronidazole for treatment of vaginal trichomoniasis." @default.
- W2028972225 created "2016-06-24" @default.
- W2028972225 creator A5010142173 @default.
- W2028972225 creator A5020440068 @default.
- W2028972225 creator A5027241396 @default.
- W2028972225 creator A5032667185 @default.
- W2028972225 creator A5034356041 @default.
- W2028972225 date "1988-02-01" @default.
- W2028972225 modified "2023-10-15" @default.
- W2028972225 title "Cancer After Exposure to Metronidazole" @default.
- W2028972225 cites W114135256 @default.
- W2028972225 cites W127994275 @default.
- W2028972225 cites W1552932328 @default.
- W2028972225 cites W1844167346 @default.
- W2028972225 cites W1958805324 @default.
- W2028972225 cites W1967502884 @default.
- W2028972225 cites W1973021490 @default.
- W2028972225 cites W2007333805 @default.
- W2028972225 cites W2015316508 @default.
- W2028972225 cites W2019211373 @default.
- W2028972225 cites W2024661574 @default.
- W2028972225 cites W2025715952 @default.
- W2028972225 cites W2039805951 @default.
- W2028972225 cites W2042361348 @default.
- W2028972225 cites W2050296896 @default.
- W2028972225 cites W2051579564 @default.
- W2028972225 cites W2075808309 @default.
- W2028972225 cites W2089925099 @default.
- W2028972225 cites W2093375611 @default.
- W2028972225 cites W2122746434 @default.
- W2028972225 cites W2145162607 @default.
- W2028972225 cites W2227123350 @default.
- W2028972225 cites W2322739260 @default.
- W2028972225 cites W2395544761 @default.
- W2028972225 cites W2408026452 @default.
- W2028972225 cites W2412847930 @default.
- W2028972225 doi "https://doi.org/10.1016/s0025-6196(12)64947-7" @default.
- W2028972225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3339906" @default.
- W2028972225 hasPublicationYear "1988" @default.
- W2028972225 type Work @default.
- W2028972225 sameAs 2028972225 @default.
- W2028972225 citedByCount "69" @default.
- W2028972225 countsByYear W20289722252012 @default.
- W2028972225 countsByYear W20289722252013 @default.
- W2028972225 countsByYear W20289722252015 @default.
- W2028972225 countsByYear W20289722252016 @default.
- W2028972225 countsByYear W20289722252019 @default.
- W2028972225 countsByYear W20289722252021 @default.
- W2028972225 crossrefType "journal-article" @default.
- W2028972225 hasAuthorship W2028972225A5010142173 @default.
- W2028972225 hasAuthorship W2028972225A5020440068 @default.
- W2028972225 hasAuthorship W2028972225A5027241396 @default.
- W2028972225 hasAuthorship W2028972225A5032667185 @default.
- W2028972225 hasAuthorship W2028972225A5034356041 @default.
- W2028972225 hasConcept C102803821 @default.
- W2028972225 hasConcept C107130276 @default.
- W2028972225 hasConcept C121608353 @default.
- W2028972225 hasConcept C126322002 @default.
- W2028972225 hasConcept C143998085 @default.
- W2028972225 hasConcept C2776256026 @default.
- W2028972225 hasConcept C2777023796 @default.
- W2028972225 hasConcept C2777396551 @default.
- W2028972225 hasConcept C2778220009 @default.
- W2028972225 hasConcept C29456083 @default.
- W2028972225 hasConcept C44249647 @default.
- W2028972225 hasConcept C501593827 @default.
- W2028972225 hasConcept C71924100 @default.
- W2028972225 hasConcept C86803240 @default.
- W2028972225 hasConcept C89423630 @default.
- W2028972225 hasConcept C89484641 @default.
- W2028972225 hasConceptScore W2028972225C102803821 @default.
- W2028972225 hasConceptScore W2028972225C107130276 @default.
- W2028972225 hasConceptScore W2028972225C121608353 @default.
- W2028972225 hasConceptScore W2028972225C126322002 @default.
- W2028972225 hasConceptScore W2028972225C143998085 @default.
- W2028972225 hasConceptScore W2028972225C2776256026 @default.
- W2028972225 hasConceptScore W2028972225C2777023796 @default.
- W2028972225 hasConceptScore W2028972225C2777396551 @default.
- W2028972225 hasConceptScore W2028972225C2778220009 @default.
- W2028972225 hasConceptScore W2028972225C29456083 @default.
- W2028972225 hasConceptScore W2028972225C44249647 @default.
- W2028972225 hasConceptScore W2028972225C501593827 @default.
- W2028972225 hasConceptScore W2028972225C71924100 @default.
- W2028972225 hasConceptScore W2028972225C86803240 @default.
- W2028972225 hasConceptScore W2028972225C89423630 @default.
- W2028972225 hasConceptScore W2028972225C89484641 @default.
- W2028972225 hasIssue "2" @default.
- W2028972225 hasLocation W20289722251 @default.
- W2028972225 hasLocation W20289722252 @default.
- W2028972225 hasOpenAccess W2028972225 @default.
- W2028972225 hasPrimaryLocation W20289722251 @default.
- W2028972225 hasRelatedWork W137958501 @default.
- W2028972225 hasRelatedWork W1964506433 @default.
- W2028972225 hasRelatedWork W1980177095 @default.
- W2028972225 hasRelatedWork W2006153715 @default.
- W2028972225 hasRelatedWork W2029449042 @default.
- W2028972225 hasRelatedWork W2055064558 @default.
- W2028972225 hasRelatedWork W2097304393 @default.